Broadening the clinical use of platinum drug–based chemotherapy with new analogues

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.16, Iss.7, 2007-06, pp. : 1009-1021

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The drug-based pipeline against restenosis

By Keller Pierre-Frédéric Ibrahim Reda Tardif Jean-Claude

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 1, 2005-02 ,pp. : 67-86

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenomics of platinum-based chemotherapy in NSCLC

By Hildebrandt Michelle AT Gu Jian Wu Xifeng

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 7, 2009-07 ,pp. : 745-755

Informa Healthcare

Access to resources Recommend Favorite

Lobaplatin: a new antitumour platinum drug

By McKeage M.J.

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 1, 2001-01 ,pp. : 119-128

Informa Healthcare

Access to resources Recommend Favorite

ZD 0473: overcoming resistance to platinum-based chemotherapy

Inpharma, Vol. 1, Iss. 1317, 2001-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Ligand based Drug Design of New Heterocyclic Imines of GABA Analogues: A Molecular Docking Approach for the Discovery of New GABA-AT Inhibitors

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 17, Iss. 1, 2017-02 ,pp. : 58-63

Bentham Science Publishers

Access to resources Recommend Favorite